TETRAPHASE PHARMACEUTICALS INC 3 SEC Filings

Filed On	Filing
11 Aug 2020	Form 3: Ttp Merger Sub, Inc., 10% owner Holds 3,737,360 shares of Common Stock, par value $0.001 per share
07 Aug 2020	Form 3: La Jolla Pharmaceutical Holdings, Llc, 10% owner Holds 1,085,000 shares of Common Stock, par value $0.001 per share
22 Jun 2020	Form 3: La Jolla Pharmaceutical Co, 10% owner Holds 850,302 shares of Common Stock
31 Jan 2020	Form 3: Armistice CAPITAL, Llc, Director and 2 others Holds 1,419,507 shares of Common Stock, $0.001 par value
31 Jan 2020	Form 3: Maher Illya Keith, Director No securities owned
20 Mar 2018	Form 3: Watt Christopher, SVP, Finance Holds 19,114 shares of Common Stock
06 Mar 2018	Form 3: Edwards Larry G., Chief Operating Officer Holds 28,032 shares of Common Stock
04 Jan 2018	Form 3: Tsai Larry, Chief Medical Officer Holds 28,166 shares of Common Stock
18 Oct 2017	Form 3: Unninayar Kamalam, Chief Financial Officer No securities owned
10 Jun 2016	Form 3: Dumas Jacques, Chief ScientificOfficer
15 Jan 2016	Form 3: Watt Christopher, VP, Finance
16 Apr 2015	Form 3: Henwood Geraldine, Director No securities owned
05 Mar 2015	Form 3: Stahl Maria D, SVP and General Counsel No securities owned
06 Feb 2015	Form 3: Fmr Llc, 10% owner Holds 671,912 shares of Common Stock
17 Jun 2014	Form 3: Chodakewitz Jeffrey, Director No securities owned
12 Mar 2014	Form 3: Wysenski Nancy, Director No securities owned
05 Feb 2014	Form 3: Thompson John Craig, Chief Operating Officer No securities owned
19 Mar 2013	Form 3: Gage L Patrick, Director
19 Mar 2013	Form 3: Xiao Xiao-Yi, 10% owner Holds 8,620 shares of Common Stock
19 Mar 2013	Form 3: Flagship Ventures Fund 2004 L P, 10% owner and 5 others

Comments